SCHEMBL10107738

SCHEMBL10107738

Cc1cccc(F)c1C(=O)NCc1ccc2c(c1)OCO2

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.68
CRHBP P24387 1/20 0.68
RECQL P46063 1/20 0.68
CRHR2 Q13324 1/20 0.68
HPGD P15428 4/20 0.66
TSHR P16473 3/20 0.66
ALDH2 P05091 1/20 0.65
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
LMNA P02545 2/20 0.62
MAPK1 P28482 2/20 0.62
MMP13 P45452 1/20 0.62
NPC1 O15118 1/20 0.61
TDP1 Q9NUW8 2/20 0.60
GAA P10253 1/20 0.57
POLB P06746 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107753 0.92 ALDH2 (0.73) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL1394364 0.92 TP53 (0.76) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL12629146 0.86 TP53 (0.68) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL10107741 0.85 ALDH2 (0.65) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL20830056 0.81 HPGD (0.72) TP53HPGDTSHRMEN1KMT2A
SCHEMBL503808 0.79 ALDH2 (1.00) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL10107759 0.79 TP53 (0.61) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL13435822 0.79 TP53 (0.61) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL10120105 0.79 ALDH2 (0.72) TP53CRHBPRECQLCRHR2HPGD
SCHEMBL16864898 0.79 TP53 (0.64) TP53CRHBPRECQLCRHR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-12 US disclosed
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010248-A1 Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof ALDH2, ALDH5A1, AK2 TP53 2919/4885CRHBP 3568/4885RECQL 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.